Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System

Overview of attention for article published in Pharmacoepidemiology & Drug Safety, January 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 2 news outlets
blogs: 2 blogs

twitter: 7 X users
facebook: 1 Facebook page

Readers on

mendeley: 45 Mendeley

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 10,049 followers.

RT @Manugrillo2: Prospective surveillance pilot of #rivaroxaban safety within the FDA. An indication of a lower risk of ischemic stroke in…

Prospective surveillance pilot of #rivaroxaban safety within the FDA. An indication of a lower risk of ischemic stroke in the rivaroxaban group compared with warfarin was detected early and persisted with additional monitoring and sensitivity analysis …

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 6 additional X posts.